Employment Agreement for J.R. LeShufyEmployment Agreement • October 13th, 2005 • Glyconix Corp • New York
THIS EMPLOYMENT AGREEMENT (the “Agreement”) is dated as of March 30, 2005, between Glyconix, Corp., a Delaware corporation (the “Company”) and J. Robert LeShufy (the “Executive”).
LICENSE AGREEMENT University of Michigan Files #894d1, 930, 1089, 1089c1, 1167, 1167c1, 1167c2, 1580, 1580d1License Agreement • May 4th, 2006 • Glyconix Corp • Medicinal chemicals & botanical products • Michigan
This Agreement is effective as of January 20, 2006 (the “Effective Date”), between Glyconix Incorporated (“LICENSEE”) having the address in Article 13 below, and the Regents of the University of Michigan, a constitutional corporation of the State of Michigan (“MICHIGAN”), having the address in Article 13 below. LICENSEE and MICHIGAN agree as follows:
CONSULTING AGREEMENT WITH L. JACOBSConsulting Agreement • June 21st, 2006 • Glyconix Corp • Medicinal chemicals & botanical products • New York
Consulting agreement for Quantum (Whitehaven) Financial Partners LLCConsulting Agreement • December 14th, 2005 • Glyconix Corp • Medicinal chemicals & botanical products • New York
Consulting agreement for Millenium Management LLCConsulting Agreement • December 14th, 2005 • Glyconix Corp • Medicinal chemicals & botanical products • New York
Globalvest Partners, LLCFinder's Fee Agreement • May 4th, 2006 • Glyconix Corp • Medicinal chemicals & botanical products
Consultant Agreement for Rifat Pamukcu January 15, 2004 Dr. Rifat PamukcuConsultant Agreement • October 13th, 2005 • Glyconix Corp • New York
Employment Agreement for Lucy OstrovskyEmployment Agreement • October 13th, 2005 • Glyconix Corp • New York
THIS EMPLOYMENT AGREEMENT (the “Agreement”) is dated as of August 1, 2005, between Glyconix, Corp., a Delaware corporation (the “Company”) and Lucy Ostrovsky (the “Employee”).
DISTRIBUTION AND SALE AGREEMENTDistribution and Sale Agreement • January 20th, 2006 • Glyconix Corp • Medicinal chemicals & botanical products
This distribution and sale agreement (the “Agreement”), as of 12 November, 2003 is made by and between Glyconix Corp. (the “Company”) having an address of 350 Fifth Avenue, Suite 4811, New York, NY 10118 and Studsvik Medical AB (“Studsvik”) having an address of 61182 Nykoping, Sweden.
SUBSCRIPTION AGREEMENTSubscription Agreement • December 14th, 2005 • Glyconix Corp • Medicinal chemicals & botanical products • New York
The attached Investor Questionnaire (“Questionnaire”) and this Subscription Agreement (the Questionnaire and this Subscription Agreement being collectively referred to herein as the “Agreement”) is made as of the ____ day of August 2004 by and between Glyconix Corp., a Delaware corporation (the “Company”), and the undersigned (the “Investor”, and collectively with all other investors, the “Investors”). Before executing this Agreement, the Investor read the Executive Summary that the Company provided to each Investor.
